Mark Dybul - Aug 25, 2022 Form 4 Insider Report for Enochian Biosciences Inc (RENB)

Role
Chief Executive Officer, Director
Signature
/s/ Mark R. Dybul
Stock symbol
RENB
Transactions as of
Aug 25, 2022
Transactions value $
$0
Form type
4
Date filed
9/15/2022, 12:36 PM
Previous filing
Jul 22, 2021
Next filing
Feb 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RENB Option to purchase shares of common stock Award $0 +350K $0.00 350K Aug 25, 2022 Common stock 350K $2.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest ratably on August 25, 2023, August 25, 2024 and August 25, 2025.